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Cartilage hair hypoplasia is a rare autosomal recessive form of short-limbed dwarfism associated with a 
cellular immunodeficiency. In eight patients, the authors studied the presence of T cell subsets and in vitro T 
cell function in order to address the basis for the immunological disorder. Both the proliferative response to 
phytohaemagglutinin (PHA) and the PHA-induced IL2 production were 60% lower compared with controls 
(P =  0.007 and 0.005, respectively). The impaired proliferative response could not be restored by addition of 
IL-2. This result is in accordance with a decrease in the percentage of activated T cells expressing the p 55 
subunit of the IL-2 receptor complex (CD25). The results define more precisely that T cells from cartilage hair 
hypoplasia patients are defective in the transition from the Go to the Gi phase of the cell cycle. Furthermore, 
the data demonstrate that several CHH patients show a reduced proportion of CD45RA"1“ ‘naive5 T cells. 
However, the in vitro impairment of T cell function cannot solely be explained by imbalance between ‘naive’ 
and ‘memory’ T cells. Although CHH patients with a history of recurrent respiratory tract infections showed 
the most aberrant in vitro immune parameters, a clear relationship between clinical data and in vitro 
parameters could not be established for the whole patient group.
Dr B.J.M. Zegers, Department o f Immunology, Wilhelmina Kinderziekenhuis, PO Box 18009, 3501 CA 
Utrecht, the Netherlands
INTRODUCTION
Cartilage-hair hypoplasia (CHH) is an autosomal recessive dis­
order comprising metaphyseal chondrodysplasia characterized 
by short-limbed dwarfism, fine sparse hair and an impaired cell 
mediated immunity. The clinical characteristics have originally 
been described in patients belonging to the Old Order Amish in 
the United States [1] and in Finns [2, 3]. The gene for CHH has 
been assigned to chromosome 9 [4], but has not been identified 
yet.
The impaired cell mediated immunity is indicated by lympho­
penia, a decreased in vitro lymphocyte reactivity to mitogens, 
antigens and allogeneic cells [5-10] and by an increased sus­
ceptibility to infections in some patients [8 , 10]. The humoral 
immunity was found to be intact [11]. Intrinsic defects in the 
proliferation of T cells, B cells and fibroblasts have been 
described previously [6]. T cell proliferation is dependent on a 
multiplicity of inter-related events such as the induction of 
interleukin-2 (IL2) and its own receptor (IL2-R) in the early 
Gi phase and the receptor for transferrin in the late G^  phase
[12, 13], Binding of IL2 to its own receptor is the actual signal 
which drives T cell entry into DNA synthesis. To test the 
hypothesis that T cell dysfunction in CHH patients is caused 
by certain defective steps in the transition of T cells from Go- 
phase into the Gr  and the S-phase of the cell cycle, we 
investigated IL2 production in peripheral blood mononuclear 
cells (PBMC) and the induction of the transferrin-receptor 
(CD71) and the p55 subunit of the IL2-R (CD25) in CD4+ and 
CD8'1' T cells. In addition to a T celi defect, the immunological 
disorder in CHH patients can also be the consequence of an 
imbalance in the ‘naive5 and 4memory’ T cells. This has been 
described to occur in a number of diseases [14-16], but the 
proportions of ‘naive’ and ‘memory’ T cell subsets in patients 
with CHH have not yet been assessed. Therefore, we assessed the 
fractions of CD45RA+ (‘naive’) and CD45R0+ T (‘memory’) T 
cells.
It was shown that the PHA-induced IL2 production is impaired 
in CHH patients. The impaired proliferative response could not 
be restored by exogenous IL2. This result is in accordance with 
our finding that the expression of the p55 subunit of the IL2-R
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following in vitro T cell activation is also reduced. In addition, 
several CHH patients show reduced proportions of CD45RA+ 
‘naive’ T cells.
MATERIALS AND M ETHODS
Subjects. The patients were physically examined by one of the authors 
(CvdB, AH, CW). The diagnosis of CHH was based on the presence of 
disproportionate short stature because of metaphyseal chondrodysplasia, 
fair but slowly growing hair and a dysfunction of the cell-mediated 
immunity. Patients 1, 2, 3, 7, and 8 have been described previously [10]. 
The clinical findings of the eight patients are summarized in Table L 
Recurrent infections were defined according to Plebani et a i [17] as the 
occurrence of at least seven episodes of infection within 1 year, five or 
more episodes/year during 2 years, or at least three episodes/year during
3 years. Patients that fulfil these conditions are considered to have been 
immunodeficient during this period.
The control group for the patients consisted of healthy adult volun­
teers between 20 and 45 years of age. The results of mitogen-induced 
DNA-synthesis and IL2 production of children of the age of our patients 
and adults are not significantly different ([18, 19] and own unpublished 
observations).
Reagents, Biotinylated goat anti-mouse IgG was purchased from 
Oncogene Science (Manhasset, NY, USA). CD29 [4B4] was obtained 
from Coulter Electronics (Luton, UK) and tricolour-conjugated strepta- 
vidin from Caltac (San Francisco, CA, USA). The MoAbs CD45RA 
(leu 18), CD45R0 (UCHL1), CD25, CD71 and lineage specific MoAbs 
were obtained from Becton Dickinson (Mountain View, CA, USA). 
Phytohaemagglutinin (PHA; HA 15) was purchased from Wellcome 
(Dartford, UK) and IL2 from Boehringer Mannheim (Mannheim, 
Germany),
Ceils. Peripheral blood was drawn from patients and healthy adult 
donors by venapuncture, and PBMC were purified as described pre­
viously [20]. The blood from the patients was taken in a period when 
they were in good health.
Immunofluorescence. For two-colour flowcytometry, PBMC 
(0.5 x  106) were labelled with a 1:10 dilution of fluorescein isothyo- 
cyanate (FITC)- and PE-labelled antibodies in minimal essential 
medium (MEM) containing 1% BSA and 0.02% NaN3 (MEM/BSA/ 
N3). After 30 min incubation at 50°C, the cells were washed twice in 
MEM/BSA/N3, at 50°C. T cell subsets were assessed by labelling with 
the following antibody combinations: anti-ab-FITC with anti-gd-PE; 
CD4-FITC with either CD45R0-PE or CD45RA-PE; and CD8-FITC 
with either CD45R0-PE or CD45RA-PE. Subsequently, cells were 
incubated with FITC-conjugated MoAbs against lineage-specific mar­
kers (CD4 or CDS) and PE-labelled CD45RO. Flow cytometric analysis 
was performed as described previously [21].
Cell cultures. To assay DNA synthesis, PBMC were cultured in the 
presence of 40 ptg/ml PHA or lOU/ml IL2 in RPMI (Gibco) containing 
10% FCS (Gibco) as described earlier [20], To determine IL2 production 
and the induction of activation markers (CD25 and CD71), cells were 
cultured with 40/ig/ml PHA in flat-bottomed microtitre plates at a 
concentration of 5 x 105 lymphocytes/well. After 18 h the supernatant 
from 10 wells was pooled into two fractions and the IL2 concentration in 
the medium was determined using an ELISA system from Amersham 
International (Amersham, UK). The expression of activation markers 
(CD25 and CD71) on the cells was performed by flow cytometric 
analysis as described above.
Statistical analysis. Significant differences (P < 0.05) between 
patients and controls were calculated by using the Mann-Whitney U- 
test (nonpaired Wilcoxon test). Since the distributions were asymmetric 
for several T cell subsets, the arithmetic mean and SD cannot be used as 
measures for central tendency and population dispersion. For this reason
Table 1. Clinical features and immunological findings in eight CHH patients
Patients Pt. 1
Sib-pair
Pt. 2 Pt. 3 Pt. 4 Pt. 5
Sib-pair
Pt. 6 Pt. 7 Pt. 8
Sex and age in years 
Clinical features
Recurrent respiratory tract infections in childhood 
Severe varicella infection3 
Height (m)
GH therapy for 2 years 
Results
Low proportion of CD45RA+ cells within the CD4+ subseth 
Low proportion of CD45RA+ cells within the CD8+ subsetb 
Proliferative response to PHAC 
IL2 production1
F/37
+
+
1.40
+
+
29
141
M/12
1.07
+
- + ~
17
3
F/12
1.38
+
43
22
M/25
+
1.49
+
+
nd*
12
F/10
4"
1.04
+
+
21
22
F/7
1.10
+
63
31
F/35
1.41
90
36
F/36
1.35
67
60
a Normal (—) or severe (+) varicella infection is indicated. 
b Below the 5th percentile of contrôles,
c As a percentage of normal mean values for the proliferative response and the IL2 production. The proliferative response for CHH patients ranged 
from 2626 to 13,748 0pm, and the IL2 production from 33 to 1464pg/ml.
*nd =  not determined.
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median and interquartile ranges (P25 and P75) were used as quantitative 
descriptors of cell population distribution. Since many observed immu­
nological abnormalities varied widely between the patients, values for 
individual patients were compared with values for controls and con­
sidered as aberrant when they were below the 5th percentile (<P5) or 
above the 95%ile (>P95) of the control group.
RESULTS
CD4+ and CD8+ T cell subsets in peripheral blood 
mononuclear cells
The percentages of various different lymphocyte subsets in 
Ficoll-Paque isolated PBMC of the patients and the controls 
are presented in Table 2. Since age-effects on the proportions of 
CD4+ and CD8+ T cell subsets are not significant for children 
older than 7 years of age [22, 23] the values for all patients, 
ranging in age from 7 to 37 years, were compared with the values 
for adult controls.
All but one patient showed a moderately reduced number of 
Ficoll-Paque-isolated PBMC. In six patients, the number was 
below the 5th percentile (<P5) value of controls (Table 2). The 
finding of reduced numbers of PBMC is in agreement with earlier 
documented lymphopenia in the patients [10]. Flow cytometric 
analysis also showed that no blast-like cell fraction was present. 
A reduced percentage of CD8+ cells (< P5) was found in four 
patients (pt. 2, 3, 4 and 8), whereas a reduced percentage of 
CD4+ T cells was observed in only one patient (Pt. 2). A reduced 
proportion of T cells with the ce/3 T cell receptor was found in 
patient 2, and T cells with the yd T cell receptor were propor­
tionally increased in pt. 2 and his twin sister pt. 3, but present in 
normal concentrations in the other patients tested (Table 2).
Naive and memory T cell subsets
Although the correlation is not complete, CD45RA and CD45R0
Table 2. Percentages of T cell subsets in CI-IH patients and controls
Pt. 1 Pt. 2 Pt. 3 Pt. 4 Pt. 5
PBMCb 650J. 710| 1550 4101 5701
CD4+ 36 8.8i 37 35 28
CD8+ 22 12i 15| 6.81 20
CD4/CD8 ratio 1.6 0.7| 2.5 5.2T 1.4
TcR ajS+c 55 18| 44 nd* nd
TcR y8+ 3.5 17| l i t nd nd
a Data are expressed as medians with ranges from the 25 th to the 75th 
b Absolute number of cells in Ficoll-paque-isolated PBMC per mm3. 
c TcR =  T cell receptor.
|  Proportion of cells above the 95th percentile of controls.
I Proportion of cells below the 5th percentile of controls.
$ Significantly different from controls (P < 0.05).
*nd =  not determined.
mark ‘naive’ and ‘memory’ T cells, respectively [24]. Flow 
cytometric analysis revealed that the proportion of CD45RA"1" 
cells within the CD4+ subset of pts. 1, 2, 4 and 5 was below the 
P5 values for controls (Table 3). In these patients, the proportion 
of CD45R0‘I" cells was increased (as could be expected) because 
both isoforms of CD45 are mutually exclusive on most T 
cells. Since a large proportion of immature thymocytes are 
CD45RA~CD45R0+ [25, 26], we tested whether the increased 
percentage of CD45R0+ cells can be explained by the presence 
of immature thymocytes. However, immature double-positive 
(CD4+‘CD8'i~) cells were not found in the peripheral blood of any 
patient. An increased proportion of CD45RA+ cells was found in 
patients 3, 6 and 7 (>P95). However, it should be noted that the 
percentage of CD45RA+ cells within CD4~h cells in children 
from 7 to 17 years of age has been shown to be about 60% 
compared with about 40% in adults [27, 28]. This indicates that 
patient 6 , because of his young age, has a normal percentage of 
naive CD4+ T cells and that patients 3 and 7 have increased 
percentages. Furthermore, the effect of age on naive CD44" T 
cells implies that imbalance between CD45RA+ and CD45R0+ 
cells in the young patients 2 and 5 is even more pronounced, as 
appears in Table 3. The finding that there is an imbalance 
between the ‘naive’ and ‘memory’ subsets in most of the patients 
is supported by the results with the marker CD29, which is 
preferentially expressed on ‘memory’ T cells [29] (Table 3). 
With respect to ‘naive’ cells within the CD8+ subset patients 1 
and 4, both adults, showed low expression of CD45RA (Table 3). 
Notably, the lowest proportions of CD45RA+ cells in the CD8”h 
subset were found in the three patients that also showed a low 
proportion of CD45RA+ cells within the CD4’1“ subset (Table 3: 
patients 1, 2 and 4).
DNA synthesis and IL2 production
The mean in vitro proliferative response of CHH lymphocytes
Pt. 6 Pt. 7 Pt. 8 Patients'1 Controls3
6301 760 490| 640 (550-722) 1130 (911-1610)
40 49 44 37 (33-41) 40 (36-47)
20 111 9.01 14 (11-20) 21 (18-25)
2.0 4.3| 4.91 2.3 (1.6-4.4) 1.9 (1.4-2.4)
nd 64 54 54 (44-55) 61 (55-68)
nd 2.3 2.8 3.5 (2.8-11)$ 2 (1.3-3.8)
percentiles in parenthesis, n — 32 for controls.
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Pt, I Pt. 2 Pt. 3 P t 4 Pt. 5 Pt. 6 Pt. 7 Pt. 8 Patientsb Controls’3
CD4 %CD45RA+ 91 161 83 Î 31 261 62Î 63Î 47 37 (14-62) 43 (30-60)c
CD4 %CD45R0+ 83Î 77T 261 92Î 69T 41 281 47 58 (38-78) 45 (35-65)
CD4 %CD29+ 62Î 68Î 251 nd* 58 341 40 46 48 (37-60) 47 (42-54)
CD8 %CD45RA+ 29i 39 68 281 66 77 73 61 63 (36-69) 67 (61-75)
CD8 %CD45R0+ 50 35 17 53 38 121 17 39 36 (17-42) 26 (22-36)
CD8 %CD29+ 82Î 77Î 46 nd 51 30 41 37 51 (35-58) 39 (31-47)
a The percentage of CD45RA+, CD45R0+ and CD29+ cells were determined on PBMC gated for either CD4 or CD8. 
b Data are expressed as medians with ranges from the 25th to the 75th percentiles in parenthesis, n — 15 for controls.
c Values obtained by others for the %CD45RA on CD4+ T cells of 7-17-years-old children and adults are 61 (55-67) and 40 (32-49), respectively 
(29).
f Proportion of cells above the 95th percentile of controls.
1 Proportion of cells below the 5th percentile of controls.
*nd s= not determined.
to PHÀ was significantly reduced compared with controls 
(P < 0.026; Fig. 1). The IL2 production in PBMC from CHH 
patients is significantly lower compared with controls (P =  
0.005; Fig, 1), and there is no relation between the IL2 produc­
tion in the first 18 h after activation and the expression of DNA 
synthesis (see also Table 1). The impaired response could not be 
restored by exogenous IL2 (Fig. 1).
To assess to what extent reduced T cell proportions in PBMC 
are responsible for the impaired in vitro proliferation and IL2 
production, we determined the percentage of T cells (CD3+) in
PBMC of each patient (Fig. 1). It appears that there is no relation 
between the T cell proportion and IL2 production, and that the 
IL2 production is much more reduced than the proportion of T 
cells. On the other hand, the lowest proliferation is found in 
patients with the smallest proportion of T cells (patients 1, 2, 3 
and 5). However, the proliferative response is more reduced than 
the percentage of T cells (Fig. 1).
To address the responsiveness of resting (unstimulated) 
PBMC from CHH patients to IL2, we tested whether IL2 could 
induce DNA synthesis. It has been established that a small
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Fig. 1. PHA-induced IL2 production and DNA synthesis. PBMC were stimulated with 40ju.g/ml PH A. The concentration of IL2 in the culture 
medium was determined after an 18 h incubation period using an ELISA. To measure DNA synthesis, 2-days-old cultures were pulsed with 
3H-thymidine for 18 h. To assess the effect of JL2 on the PHA-induced DNA synthesis, lOU/ml IL2 was added together with PHA. Median values 
and ranges from 25th to 75th percentiles are represented as horizontal bars and vertical bars, respectively. *P < 0.001 compared with controls.
The legend on the right side of the figure indicates the percentage of T cells in the cell cultures for each patient and for the controls (median; 
P25-P75),
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fraction of PBMC express receptors for IL2 and will enter the 
S-phase in response to IL2 [30]. The induction of DNA 
synthesis by IL2 showed no differences between patients and 
controls. Furthermore, the patients that responded poorly to 
PHA (patients 1, 2 and 5) exhibited moderate responses to 1L2 
(data not shown).
Expression of 1L2 receptors (CD25) and transferrin receptors by
PHA
To address the events which occur during the transition from the 
Gq to the Gj phase of the cell cycle, we determined the 
expression of the p55 subunit (CD25) of the IL2-R complex, 
and the expression of transferrin receptors (CD71) at 18 and 40 h 
after activation with PHA. Figure 2A reveals that the expression 
of CD71 in CD4"1" T cells from CHH patients was normal. The
proportion of CD25+ cells 18 h after stimulation was slightly 
lower in CHH patients compared to controls (Fig. 2B). After 
40 h, the mean expression of CD25 was significantly less on 
CD4+ cells from CHH patients (P =  0.05). Furthermore, in 
patients 1, 2 , 4, 5 and 6 the proportion of CD25+ cells decreased 
between 18 and 40 h after activation (Fig. 2B). This phenomenon 
was never observed in activated cells from controls.
Similar to that observed for CD4+ cells, the expression of 
CD71 on CD8+ cells at 18 h was not different from the controls 
(Fig. 2C), However, at 40 h, we found a relatively low proportion 
of CD71+ cells in three patients (patients 1, 2 and 4). The mean 
percentage of CD25+ within the CD84" population from CHH 
patients was not significantly different from controls at 18 h after 
stimulation (Fig. 2D), but at 40 h the proportion of CD25+ cells 
was significantly lower compared with controls (P =  0.015). 
The proportion of CD25+ cells was relatively low in one patient
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Fig. 2. Induction of transferrin receptors (CD71) and p55 subunits of the IL2 receptor (CD25) in CD4+ and CD8+ cells. PBMC were cultured in 
the presence of PHA. After 18 and 40 h, the percentage of CD25’1' and CD71+ cells within the CD4+' and CD8+ subsets was determined using 
two-colour flow cytometry. The figures represent the percentage of CD4 or CD8 gated cells that expressed CD25 or CD71. (A) CD71 expression 
on CD4+ cells; (B) CD25 expression on CD4+ cells; (C) CD71 expression on CD8+ cells; (D) CD25 expression on CD8+ cells, Median values 
and ranges from 25th to 75th percentiles are represented as horizontal bars and vertical bars, respectively. *P < 0.05 compared with controls.
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at 18 h after stimulation and in three patients at 40 h after 
stimulation. Notably, despite a relatively normal expression of 
CD25 in patients 1 and 4, the percentage CD25"1' cells decreased 
between 18 and 40 h after stimulation.
DISCUSSION
The T lymphocyte defect in CHH patients is as yet not fully 
understood. Early work from Pierce & Polmar [5, 6] clearly 
showed that an intrinsic T cell defect in the proliferative capacity 
of lymphocytes does exist. We found that all but one patient 
showed an impaired production of the autocrine T cell growth 
factor IL2 as measured after 18 h of activation (Fig. 1). However, 
there is no relation between the level of IL2 production, and the 
proliferative response and addition of IL2 to the culture medium 
did not restore this response (Fig. 1). This result implies that a 
reduced production of IL2 is not the only cause of the impaired 
proliferative response, which is in accordance with our observa­
tion that the proportion of T cells that express the p55 subunit of 
the IL2 receptor (CD25) is reduced in PHA activated T cells. 
Since the IL2 induced DNA synthesis is not impaired in non­
stimulated PBMC from CHH patients (data not shown), we 
conclude that there is no defect in IL2 receptor function and 
that CHH lymphocytes have a normal capability to enter the S 
phase. Taken together, our data confirm the assumption of Pierce
& Polmar [5, 6] that there is a partial cell cycle defect in the 
transition from the G0 to the Gj phase. This hypothesis is in 
accordance with the observation that one CHH patient with 
combined immunodeficiency was found to have a defective 
expression of early activation genes like c-myc, IL2Ra, IL2 
and IFN-y as assessed by mRNA measurements [31]. Notably, in 
several patients the percentage of CD25"1" cells was lower after 
40 h compared to 18h. Therefore, we have to take into account 
the possibility that the cell cycle defect affects progression 
through the GL phase instead of, or in addition to, the transition 
from the G0 to the Gj phase. The decrease in CD25+ cells 
between 18 and 40 h suggests that certain cells will not enter the
S phase, which explains the impaired proliferative response. 
However, we cannot exclude the possibility that the peak 
response of all ceils is shifted to a later time point.
Both CD4+ and CD8+ peripheral T cells can be divided into 
CD45RA"1' and CD45R0+ subsets. Although there is no strict 
correlation, CD45RA is mainly expressed on ‘naive’ T cells 
which are not yet exposed and responsive to antigen, whereas 
CD45R0 marks the ‘memory’ T cell stage [24, 32]. In addition, 
CD29 has been shown to be mainly expressed on ‘memory’ T 
cells [24]. ‘Naive’ and ‘memory' T cells differ in responsiveness 
to mitogens and antigens, and exert different immunological 
functions. Importantly, the proliferative response to PHA and 
concomitant IL2 production is more pronounced in CD45RA4' 
‘naive’ T cells compared with the CD45R0+ ‘memory* cells [24, 
33]. Therefore, impaired T cell function as measured by in vitro 
assays using PBMC might be related to the proportion of 
CD45RA+ cells [16]. Using these maturation stage dependent 
markers, we found that the patients with the smallest proportion
of CD45RAf cells within the CD4+ population (<P5) had 
indeed the lowest proliferative response to PHA (Table 1). 
However, there was no relation between the presence of naive 
and memory T cell subsets and IL2 production. While two 
patients with a low proportion of CD45RA+ T cells show the 
lowest IL2 production (patients 2 and 4; Table 3 & Fig. 1), two 
other patients with a relatively low IL2 production (31 and 35% 
of the normal mean values) have normal percentages of CD4+ 
and CD 8 4 cells in PBMC and relatively high proportions of 
CD45RA+ cells within these subsets (patients 6 and 7). In 
addition, lymphocytes of patient 1 produced a high amount of 
IL2, in spite of a low percentage of CD45RA+ T cells (Table 3 & 
Fig. 1). These results indicate that in CHH patients a reduced 
proportion of ‘naive'1 T cells is not systematically related to a 
decreased IL2 production. We conclude that the in vitro T cell 
defects cannot be explained solely by the imbalance of ‘naive’ 
and ‘memory’ cells. On the other hand, patients with recurrent 
respiratory tract infections in childhood had the smallest propor- 
tions of ‘naive’ (CD4+ and CD8+) T cells (Tables 1 & 3). Instead 
of a primary defect, this phenomenon might be a secondary effect 
due to an increased number of infections during childhood. In 
this respect it should be noted that two adult patients that no 
longer suffer from recurrent infections still show low proportions 
of "naive" T cells (Table 1). Our finding that the majority of 
patients with CHH in our study show a reduced fraction of 
‘naive’ T cells stresses the importance of addressing these 
subsets in further clinical studies.
With respect to the clinical features we conclude that none of 
the immunological abnormalities we described is related to GH 
hormone treatment instituted in four patients (Table 1). This 
result is in agreement with earlier observations which reveal that 
GH does not have, or hardly has, any effect on the immune 
function in children [34, 35]. In a separate study [36] we 
determined type I insulin growth factor (IGF) receptor expres­
sion on T cell subsets. In healthy individuals both ‘naive’ and 
‘memory1 T cells contain type I IGF receptor positive and 
negative cells [37], Interestingly, CHH patients with a history 
of recurrent infections also showed the lowest percentage of type
I IGF receptor bearing ‘naive’ T cells both in the CD4"1" and 
CD8+ subset ([36], data not shown). There was no strict 
correlation between the PHA-induced IL2 production and occur­
rence of recurrent infections in childhood (Table 1, Fig. I), On 
the other hand, the percentage of CD25+ T cells at 40 h after 
PHA-activation was markedly lower in T cells from patients with 
a history of recurrent infections than in the other patients and 
normal controls (Fig. 2). This is also in agreement with our 
finding that the PHA-induced proliferative capacity is most 
strongly affected in patients with a history of infections.
Thus, the proliferative defect in T cells from CHH patients 
is, at least in part, caused by a reduced capability to express 
the products of early activation genes like IL2, the IL2 
receptor and the transferrin receptor. However, the nature of 
the defect that affects T cells of CHH patients is as yet 
unclear. In addition, the relationship between dysfunctional 
in vitro parameters and clinical data, although present in a
©1997 Blackwell Science Ltd, Scandinavian Journal, o f Immunology, 46, 209-215
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‘subgroup’ of the patients with recurrent respiratory tract 
infections, remains to be established.
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